BDBM50280655 3-Isobutyryloxy-benzo[4,5]thieno[3,2-b]furan-2-carboxylic acid methyl ester::CHEMBL268367
SMILES: COC(=O)c1oc2c(sc3ccccc23)c1OC(=O)C(C)C
InChI Key: InChIKey=STCBJZIZCOASHY-UHFFFAOYSA-N
Data: 5 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Coagulation factor X (Bos taurus) | BDBM50280655 (3-Isobutyryloxy-benzo[4,5]thieno[3,2-b]furan-2-car...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description In vitro concentration of compound required to inhibit 50% of Factor Xa | Bioorg Med Chem Lett 2: 1025-1028 (1992) Article DOI: 10.1016/S0960-894X(00)80611-3 BindingDB Entry DOI: 10.7270/Q2X066XV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Trypsin (Bos taurus (bovine)) | BDBM50280655 (3-Isobutyryloxy-benzo[4,5]thieno[3,2-b]furan-2-car...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article | n/a | n/a | 2.90E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description In vitro concentration of compound required to inhibit 50% of trypsin | Bioorg Med Chem Lett 2: 1025-1028 (1992) Article DOI: 10.1016/S0960-894X(00)80611-3 BindingDB Entry DOI: 10.7270/Q2X066XV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasminogen (Homo sapiens (Human)) | BDBM50280655 (3-Isobutyryloxy-benzo[4,5]thieno[3,2-b]furan-2-car...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article | n/a | n/a | 2.40E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description In vitro concentration of compound required to inhibit 50% of Plasmin | Bioorg Med Chem Lett 2: 1025-1028 (1992) Article DOI: 10.1016/S0960-894X(00)80611-3 BindingDB Entry DOI: 10.7270/Q2X066XV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Thrombin (Bos taurus (Bovine)) | BDBM50280655 (3-Isobutyryloxy-benzo[4,5]thieno[3,2-b]furan-2-car...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article | n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description In vitro concentration of compound required to inhibit 50% of 6 nM thrombin | Bioorg Med Chem Lett 2: 1025-1028 (1992) Article DOI: 10.1016/S0960-894X(00)80611-3 BindingDB Entry DOI: 10.7270/Q2X066XV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM50280655 (3-Isobutyryloxy-benzo[4,5]thieno[3,2-b]furan-2-car...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article | n/a | n/a | 7.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description In vitro concentration of compound required to inhibit 50% of Kallikrein | Bioorg Med Chem Lett 2: 1025-1028 (1992) Article DOI: 10.1016/S0960-894X(00)80611-3 BindingDB Entry DOI: 10.7270/Q2X066XV | |||||||||||
More data for this Ligand-Target Pair |